Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (91-100 of 266) with videos related to

Pageof 27
Sort By:
Parkinson'S Disease|January 25, 2021
Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical PracticeKhashayar Dashtipour, Fiona Gupta, Robert A Hauser, et al.
Parkinson'S Disease|March 10, 2021
Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary<sup>®</sup>): Results of a Nationwide Dose Conversion SurveyRobert A Hauser, Ghazal Banisadr, Kara Vuong, et al.
European Journal of Clinical Pharmacology|December 2, 2005
Treatment of chorea with levetiracetamTheresa A Zesiewicz, Amit Pathak, Kelly L Sullivan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2008
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's diseaseRobert A Hauser, Michel Panisset, Giovanni Abbruzzese, et al.
BMC Neurology|August 20, 2016
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionClément François, Gerald J Rowse, L Arthur Hewitt, et al.
Neurology and Therapy|April 17, 2021
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and DyskinesiaShyamal H Mehta, Rajesh Pahwa, Caroline M Tanner, et al.
Neuropsychiatric Disease and Treatment|November 10, 2009
Sleep disorders in Parkinson's diseaseIsrat Jahan, Robert A Hauser, Kelly L Sullivan, et al.
Plos One|December 17, 2019
Higher neuron densities in the cerebral cortex and larger cerebellums may limit dive times of delphinids compared to deep-diving toothed whalesSam H Ridgway, Robert H Brownson, Kaitlin R Van Alstyne, et al.
Clinical Neuropharmacology|June 15, 2006
Topiramate-induced psychosis in patients with essential tremor: report of 2 casesTheresa A Zesiewicz, Archer Tullidge, Jonathan Tidwell, et al.
Neurology and Therapy|May 23, 2021
Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and DyskinesiaRobert A Hauser, Shyamal H Mehta, Daniel Kremens, et al.
Pageof 27

Showing results (91-100 of 266) with videos related to

Sort By:
Pageof 27
Parkinson'S Disease|January 25, 2021
Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical PracticeKhashayar Dashtipour, Fiona Gupta, Robert A Hauser, et al.
Parkinson'S Disease|March 10, 2021
Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary<sup>®</sup>): Results of a Nationwide Dose Conversion SurveyRobert A Hauser, Ghazal Banisadr, Kara Vuong, et al.
European Journal of Clinical Pharmacology|December 2, 2005
Treatment of chorea with levetiracetamTheresa A Zesiewicz, Amit Pathak, Kelly L Sullivan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2008
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's diseaseRobert A Hauser, Michel Panisset, Giovanni Abbruzzese, et al.
BMC Neurology|August 20, 2016
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionClément François, Gerald J Rowse, L Arthur Hewitt, et al.
Neurology and Therapy|April 17, 2021
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and DyskinesiaShyamal H Mehta, Rajesh Pahwa, Caroline M Tanner, et al.
Neuropsychiatric Disease and Treatment|November 10, 2009
Sleep disorders in Parkinson's diseaseIsrat Jahan, Robert A Hauser, Kelly L Sullivan, et al.
Plos One|December 17, 2019
Higher neuron densities in the cerebral cortex and larger cerebellums may limit dive times of delphinids compared to deep-diving toothed whalesSam H Ridgway, Robert H Brownson, Kaitlin R Van Alstyne, et al.
Clinical Neuropharmacology|June 15, 2006
Topiramate-induced psychosis in patients with essential tremor: report of 2 casesTheresa A Zesiewicz, Archer Tullidge, Jonathan Tidwell, et al.
Neurology and Therapy|May 23, 2021
Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and DyskinesiaRobert A Hauser, Shyamal H Mehta, Daniel Kremens, et al.
Pageof 27